AI, ACOG, and sling-related nerve pain spark debate in women’s health

By AI, Created 11:28 AM UTC, May 20, 2026, /AGP/ – Greg Vigna, a physician-lawyer who represents women in injury cases, says patients and clinicians are increasingly turning to AI and medical literature to weigh risks tied to gynecologic devices and drugs. The discussion centers on whether transobturator slings can contribute to pudendal neuralgia, and on broader questions about how ACOG guidance reflects emerging evidence.

Why it matters: - Patients with pelvic pain may be looking beyond routine gynecology visits for answers about mesh slings, Depo-Provera, and other women’s health treatments. - The debate affects how women weigh symptom reports, device risks, and shared decision-making before and after procedures. - Greg Vigna says continued review of peer-reviewed literature and independent studies may help support informed clinical decisions.

What happened: - Greg Vigna, MD, JD, said some ACOG members may be less familiar with research linking pudendal neuralgia to soft tissue impacts from mid-urethral slings sold in the United States. - Vigna said there is ongoing discussion about how ACOG reviews position statements and supporting literature on neurological pain syndromes tied to polypropylene mid-urethral slings. - Vigna also pointed to AI-generated medical commentary in response to the question of whether a properly positioned transobturator sling can cause pudendal neuralgia. - Vigna urged patients to continue routine care, including Pap smears, and to review available medical information when discussing gynecological concerns.

The details: - The AI response cited medical literature and clinical reports suggesting mesh itself, or the body’s reaction to it, can trigger neuropathy without direct nerve transection. - The AI response said a TOT sling pierces the obturator internus muscle, and mechanical irritation can trigger chronic muscle spasms. - The AI response said spasming of the obturator internus can indirectly compress the pudendal nerve because the nerve runs within Alcock’s canal. - Vigna said published data has reported limited cases of pudendal or obturator neuralgia associated with PVDF slings, which he said may not cause the chronic inflammation seen with older polypropylene material. - Vigna said literature since 2009 has explored a potential link between transobturator slings and indirect nerve injury or pain affecting the obturator and pudendal nerves. - Vigna said proposed mechanisms include chronic inflammation from polypropylene, which may contribute to muscle spasm and scar tissue formation. - The article says some studies have reported increased myofascial pain with transobturator slings compared with retropubic slings. - The article says allodynia on physical examination has been identified in the literature as a potential indicator of neuralgia, CRPS Type 2, or Complex Regional Pain Syndrome Type 1. - The article says CRPS may be associated with dystonia. - Vigna said ACOG has published guidance on a range of women’s health procedures. - Vigna said clinicians and researchers have raised questions about whether emerging evidence on morcellators, Essure, vaginal mesh, and polypropylene mid-urethral slings is fully reflected in clinical practice. - Vigna said literature has also discussed Depo-Provera and reported associations with meningiomas. - Vigna said ACOG has not recommended a ban on Depo-Provera. - Vigna said some studies have explored associations between Depo-Provera and meningiomas, including cases involving multiple tumors. - Vigna said alternative medications with comparable effectiveness are available.

Between the lines: - The release frames AI as a research tool that may help patients compare symptoms, device design, and published studies before making treatment decisions. - The broader argument is that standard guidance may lag behind newer reports on device-related nerve pain and medication-related concerns. - The piece mixes factual claims, legal advocacy, and interpretive commentary, so the strongest takeaway is the push for patients to seek multiple sources before deciding on care.

What’s next: - Vigna says ongoing evaluation of risks and benefits for medications and procedures remains important. - He says continued review of independent peer-reviewed research may shape future counseling and treatment decisions. - Patients considering gynecological treatment may increasingly compare physician advice with AI summaries and published studies before consenting to procedures. - More information is available in ACOG’s counseling guide.